YolTech to Participate in Chardan’s 9th Annual Genetic Medicines Conference

YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene-editing therapies, will participate in Chardan’s 9th Annual Genetic Medicines Conference on October 21, 2025, at the Lotte New York Palace Hotel (455 Madison Avenue, New York). The annual conference brings together global leaders in genetic medicines, addressing emerging technologies, clinical advancements, and trends shaping the industry.

Dr. Emma Wang, Co-Founder, Chief Development Officer and Chief Technology Officer of YolTech Therapeutics, will participate in two panel discussions:

-- Genome Editing: Next Wave Technologies

Time: 8:45–9:25 AM

Venue: Villard Ballroom (2nd Floor)

-- China Perspective

Time: 3:30–4:10 PM

Venue: Reid Salon (2nd Floor)

YolTech will share insights into the development of in vivo gene-editing therapies enabled by its proprietary YolCas, YolBE, and Yol-LNPs platforms, alongside the company’s latest clinical progress demonstrating the potential of one-time, durable genetic therapies.